Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestMortgagesNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Newmark (NMRK) Total Non-Current Liabilities (2017 - 2026)

Newmark has reported Total Non-Current Liabilities over the past 9 years, most recently at $3.0 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 2.55% year-over-year to $3.0 billion; the TTM value through Dec 2025 reached $3.0 billion, up 2.55%, while the annual FY2025 figure was $3.0 billion, 2.55% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $3.0 billion at Newmark, down from $3.6 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $3.6 billion in Q2 2025 and troughed at $2.2 billion in Q4 2022.
  • A 5-year average of $3.0 billion and a median of $3.0 billion in 2024 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: increased 27.64% in 2021 and later plummeted 33.72% in 2022.
  • Year by year, Total Non-Current Liabilities stood at $3.3 billion in 2021, then plummeted by 33.72% to $2.2 billion in 2022, then grew by 19.6% to $2.6 billion in 2023, then grew by 11.61% to $2.9 billion in 2024, then grew by 2.55% to $3.0 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for NMRK at $3.0 billion in Q4 2025, $3.6 billion in Q3 2025, and $3.6 billion in Q2 2025.